Rapport Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Rapport Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate for 2023.
  • Rapport Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$17.5M, a 101% decline year-over-year.
  • Rapport Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$71.9M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$34.8M Jan 1, 2023 Dec 31, 2023 10-Q 2024-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.